0001960355 2026-03-18 2026-03-18 0001960355 1 2026-03-18 2026-03-18 0001960355 2 2026-03-18 2026-03-18 0001960355 3 2026-03-18 2026-03-18 0001960355 4 2026-03-18 2026-03-18 iso4217:USD pure S-1 S-1 EX-FILING FEES 0001960355 Exyn Technologies, Inc. N/A N/A S-1 Exyn Technologies, Inc. false Equity Units consisting of (i) Common stock, $0.0001 per share and (ii) Warrants to purchase one share of common stock true 1000000.00 0.0001381 138.10 false Equity Common stock, $0.0001 par value per share, issuable upon the exercise of the Warrants included in the units true 1000000.00 0.0001381 138.10 false Equity Representative's Warrant true 0.0001381 0.00 false Equity Common stock, $0.0001 par value per share, underlying Representative's Warrant true 31250.00 0.0001381 4.32 2031250.00 280.52 0.00 0.00 280.52 Note 1.a Maximum aggregate offering price is estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the "Securities Act"). Pursuant to Rule 416, this registration statement also covers an indeterminate number of shares of common stock, par value $0.0001 per share, of the registrant (the "Common Stock") that may become issuable to prevent dilution resulting from stock splits, stock combinations, stock dividends, recapitalizations or similar transactions with respect to the Common Stock. Note 1.b No separate fee is required pursuant to Rule 457(g) under the Securities Act. See Offering Note 1.a Note 2.a Based on an assumed per-share exercise price for the Warrants of 100% of the public offering price per unit in this offering. See Offering Note 1.a Note 3.a No separate fee is required pursuant to Rule 457(g) under the Securities Act. See Offering Note 1.a Note 4.a Represents shares of Common Stock underlying warrants issuable to the representative of the several underwriters to purchase up to an aggregate of 2.5% of the total number of shares of Common Stock included in the units sold in the offering (including any units purchased pursuant to the exercise of the over-allotment option) at an exercise price equal to 125% of the public offering price. The warrants will be exercisable at any time after the date of the closing of this offering and will expire five years from the date of closing of this offering.